These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 21862714

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. First-day step-down to oral outpatient treatment versus continued standard treatment in children with cancer and low-risk fever in neutropenia. A randomized controlled trial within the multicenter SPOG 2003 FN study.
    Brack E, Bodmer N, Simon A, Leibundgut K, Kühne T, Niggli FK, Ammann RA.
    Pediatr Blood Cancer; 2012 Sep; 59(3):423-30. PubMed ID: 22271702
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina.
    Paganini H, Gómez S, Ruvinsky S, Zubizarreta P, Latella A, Fraquelli L, Iturres AS, Casimir L, Debbag R.
    Cancer; 2003 Apr 01; 97(7):1775-80. PubMed ID: 12655535
    [Abstract] [Full Text] [Related]

  • 7. Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients.
    Park JR, Coughlin J, Hawkins D, Friedman DL, Burns JL, Pendergrass T.
    Med Pediatr Oncol; 2003 Feb 01; 40(2):93-8. PubMed ID: 12461792
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Outpatient treatment of low-risk neutropenic fever in cancer patients using oral moxifloxacin.
    Chamilos G, Bamias A, Efstathiou E, Zorzou PM, Kastritis E, Kostis E, Papadimitriou C, Dimopoulos MA.
    Cancer; 2005 Jun 15; 103(12):2629-35. PubMed ID: 15856427
    [Abstract] [Full Text] [Related]

  • 10. Ciprofloxacin in treatment of fever and neutropenia in pediatric cancer patients.
    Mullen CA.
    Pediatr Infect Dis J; 2003 Dec 15; 22(12):1138-42. PubMed ID: 14688588
    [Abstract] [Full Text] [Related]

  • 11. Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients.
    Mullen CA, Petropoulos D, Roberts WM, Rytting M, Zipf T, Chan KW, Culbert SJ, Danielson M, Jeha SS, Kuttesch JF, Rolston KV.
    Cancer; 1999 Jul 01; 86(1):126-34. PubMed ID: 10391572
    [Abstract] [Full Text] [Related]

  • 12. Oral antibiotics for fever in low-risk neutropenic patients with cancer: a double-blind, randomized, multicenter trial comparing single daily moxifloxacin with twice daily ciprofloxacin plus amoxicillin/clavulanic acid combination therapy--EORTC infectious diseases group trial XV.
    Kern WV, Marchetti O, Drgona L, Akan H, Aoun M, Akova M, de Bock R, Paesmans M, Viscoli C, Calandra T.
    J Clin Oncol; 2013 Mar 20; 31(9):1149-56. PubMed ID: 23358983
    [Abstract] [Full Text] [Related]

  • 13. Outpatient treatment with intravenous antimicrobial therapy and oral levofloxacin in patients with febrile neutropenia and hematological malignancies.
    Bellesso M, Costa SF, Pracchia LF, Santos Dias LC, Chamone D, Dorlhiac-Llacer PE.
    Ann Hematol; 2011 Apr 20; 90(4):455-62. PubMed ID: 20852999
    [Abstract] [Full Text] [Related]

  • 14. Once daily, oral, outpatient quinolone monotherapy for low-risk cancer patients with fever and neutropenia: a pilot study of 40 patients based on validated risk-prediction rules.
    Rolston KV, Manzullo EF, Elting LS, Frisbee-Hume SE, McMahon L, Theriault RL, Patel S, Benjamin RS.
    Cancer; 2006 Jun 01; 106(11):2489-94. PubMed ID: 16628654
    [Abstract] [Full Text] [Related]

  • 15. Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia.
    Bucaneve G, Micozzi A, Menichetti F, Martino P, Dionisi MS, Martinelli G, Allione B, D'Antonio D, Buelli M, Nosari AM, Cilloni D, Zuffa E, Cantaffa R, Specchia G, Amadori S, Fabbiano F, Deliliers GL, Lauria F, Foà R, Del Favero A, Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Infection Program.
    N Engl J Med; 2005 Sep 08; 353(10):977-87. PubMed ID: 16148283
    [Abstract] [Full Text] [Related]

  • 16. Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children.
    Aksoylar S, Cetingül N, Kantar M, Karapinar D, Kavakli K, Kansoy S.
    Pediatr Hematol Oncol; 2004 Mar 08; 21(2):115-23. PubMed ID: 15160510
    [Abstract] [Full Text] [Related]

  • 17. Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge.
    Sebban C, Dussart S, Fuhrmann C, Ghesquieres H, Rodrigues I, Geoffrois L, Devaux Y, Lancry L, Chvetzoff G, Bachelot T, Chelghoum M, Biron P.
    Support Care Cancer; 2008 Sep 08; 16(9):1017-23. PubMed ID: 18197434
    [Abstract] [Full Text] [Related]

  • 18. The safety profile of moxifloxacin and other fluoroquinolones in special patient populations.
    Iannini PB.
    Curr Med Res Opin; 2007 Jun 08; 23(6):1403-13. PubMed ID: 17559736
    [Abstract] [Full Text] [Related]

  • 19. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline.
    Flowers CR, Seidenfeld J, Bow EJ, Karten C, Gleason C, Hawley DK, Kuderer NM, Langston AA, Marr KA, Rolston KV, Ramsey SD.
    J Clin Oncol; 2013 Feb 20; 31(6):794-810. PubMed ID: 23319691
    [Abstract] [Full Text] [Related]

  • 20. Early hospital discharge versus continued hospitalization in febrile pediatric cancer patients with prolonged neutropenia: A randomized, prospective study.
    Ahmed N, El-Mahallawy HA, Ahmed IA, Nassif S, El-Beshlawy A, El-Haddad A.
    Pediatr Blood Cancer; 2007 Nov 20; 49(6):786-92. PubMed ID: 17366527
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.